Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Arpa Ebrahimi"'
Autor:
Stanislau Stanisheuski, Arpa Ebrahimi, Kavi Aashish Vaidya, Hyo Sang Jang, Liping Yang, Alex Jordan Eddins, Carrie Marean-Reardon, Maria Clara Franco, Claudia Susanne Maier
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
In this study, we adapted an HP D100 Single Cell Dispenser – a novel low-cost thermal inkjet (TIJ) platform with impedance-based single cell detection – for dispensing of individual cells and one-pot sample preparation. We repeatedly achieved lab
Externí odkaz:
https://doaj.org/article/465f59b7165f450ba8f5f6fc4b48c994
Autor:
Jamie Valeich, Dan Boyd, Manu Kanwar, Daniel Stenzel, Deblina De Ghosh, Arpa Ebrahimi, James Woo, Jenny Wang, Alexandre Ambrogelly
Publikováno v:
Antibodies, Vol 9, Iss 4, p 50 (2020)
A variety of Fc domain engineering approaches for abrogating the effector functions of mAbs exists. To address some of the limitations of the current Fc domain silencing approaches, we are exploring a less commonly considered option which relies on t
Externí odkaz:
https://doaj.org/article/536aa11a0895400d9b3bf9dacf2aa0f6
Autor:
James Woo, Manu Kanwar, Jenny Wang, Dan Boyd, Alexandre Ambrogelly, Daniel Stenzel, Jamie Valeich, Deblina De Ghosh, Arpa Ebrahimi
Publikováno v:
Antibodies
Volume 9
Issue 4
Antibodies, Vol 9, Iss 50, p 50 (2020)
Volume 9
Issue 4
Antibodies, Vol 9, Iss 50, p 50 (2020)
A variety of Fc domain engineering approaches for abrogating the effector functions of mAbs exists. To address some of the limitations of the current Fc domain silencing approaches, we are exploring a less commonly considered option which relies on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f75d35e73e68b5a88fcc20afa460b46e
http://europepmc.org/articles/PMC7709103
http://europepmc.org/articles/PMC7709103
Autor:
Darren Brown, Dan Boyd, Alexandre Ambrogelly, Jenny Wang, Arpa Ebrahimi, Brian Mickus, Matthew R. Schenauer, Sarah Ronan
Publikováno v:
mAbs. 10(3)
Isolation and characterization of monoclonal antibody (mAb) variants to understand the impact of their structure on function is a typical activity during early-stage candidate selection that contributes to derisking clinical development. In particula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e6bf6b4d8d26a3af9c3fe070917f2c
https://pubmed.ncbi.nlm.nih.gov/29537936
https://pubmed.ncbi.nlm.nih.gov/29537936